600535 Tasly Pharmaceutical Group
- 12.88
- +0.13+1.02%
Tasly Pharmaceutical Group News
Announcement from Tasly Pharmaceutical Group regarding its subsidiary's acquisition of pharmaceutical registration certificate.
Announcement of Tasly Pharmaceutical Group's wholly-owned subsidiary Pharmaceutical Fumarate Ketotifen Tablets passing the generic consistency evaluation.
Tianshili 2023 Annual Benefit Distribution Implementation Notice
Tianshili's progress announcement on providing guarantees to subsidiaries
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Tasly
Legal Opinion of Inner Mongolia Jianzhong Law Firm on the 2023 Annual General Meeting of Shareholders of Tianshili Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the 1st Meeting of the 9th Board of Directors of Tasly
Announcement of Resolutions of the 1st Meeting of the 9th Board of Supervisors of Tasly
Tasly 2024 First Quarter Report
Tianshili's announcement on the company's main operating data for the first quarter of 2024
Tessile 2023 Annual General Meeting of Shareholders Meeting Materials
Tianshili 2023 Social Responsibility Report
Tasly 2023 Annual Report
2023 Independent Director Debriefing Report (Wang Aijian)
2023 Independent Director's Debriefing Report (Xin Liu)
Report on the performance of supervisory duties by the Audit Committee of the Board of Directors of Tasman in 2023
Tianshili's Notice on Convening the 2023 Annual General Meeting of Shareholders
Tasly 2023 Annual Report Summary
Tianshili 2023 Audit Report
2023 Accounting Firm Performance Assessment Report
Analysis
Price Target
No Data
